Cargando…
Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis
• Benign metastasizing leiomyomatosis (BML) is a rare condition. • Treatment options have traditionally included surgical resection or hormonal based therapy. • Traditional chemotherapy for BML is ineffective. • Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068955/ https://www.ncbi.nlm.nih.gov/pubmed/35531358 http://dx.doi.org/10.1016/j.gore.2021.100903 |
_version_ | 1784700330643030016 |
---|---|
author | Chhabra, Shalini Sangani, Pooja Saig, Reagan Stany, Michael |
author_facet | Chhabra, Shalini Sangani, Pooja Saig, Reagan Stany, Michael |
author_sort | Chhabra, Shalini |
collection | PubMed |
description | • Benign metastasizing leiomyomatosis (BML) is a rare condition. • Treatment options have traditionally included surgical resection or hormonal based therapy. • Traditional chemotherapy for BML is ineffective. • Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of bevacizumab. |
format | Online Article Text |
id | pubmed-9068955 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-90689552022-05-05 Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis Chhabra, Shalini Sangani, Pooja Saig, Reagan Stany, Michael Gynecol Oncol Rep Case Report • Benign metastasizing leiomyomatosis (BML) is a rare condition. • Treatment options have traditionally included surgical resection or hormonal based therapy. • Traditional chemotherapy for BML is ineffective. • Our patient has had a prolonged response of stable disease with the anti-VEGF therapy of bevacizumab. Elsevier 2021-12-18 /pmc/articles/PMC9068955/ /pubmed/35531358 http://dx.doi.org/10.1016/j.gore.2021.100903 Text en © 2021 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Case Report Chhabra, Shalini Sangani, Pooja Saig, Reagan Stany, Michael Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title | Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title_full | Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title_fullStr | Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title_full_unstemmed | Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title_short | Prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
title_sort | prolonged response with bevacizumab in a patient with benign metastasizing leiomyomatosis |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068955/ https://www.ncbi.nlm.nih.gov/pubmed/35531358 http://dx.doi.org/10.1016/j.gore.2021.100903 |
work_keys_str_mv | AT chhabrashalini prolongedresponsewithbevacizumabinapatientwithbenignmetastasizingleiomyomatosis AT sanganipooja prolongedresponsewithbevacizumabinapatientwithbenignmetastasizingleiomyomatosis AT saigreagan prolongedresponsewithbevacizumabinapatientwithbenignmetastasizingleiomyomatosis AT stanymichael prolongedresponsewithbevacizumabinapatientwithbenignmetastasizingleiomyomatosis |